SRTS - Sensus Healthcare price target raised by $3 at Maxim, here's why
TheFlyontheWall.com - May 10 08:23 EDT
Maxim raised the firm's price target on Sensus Healthcare to $10 from $7 and keeps a Buy rating on the shares. The company's Q1 results were significantly above estimates, with large customer driving its sales growth, the analyst tells investors in a research note. Sensus also had $14.7M in cash and no debt, and based on Maxim's assumptions, the company may only need additional capital for acquisitions, the firm added.
I have seen lots of $1 stocks with strong earnings and solid balance sheets triple, quadruple and more, but I have yet to see one go below zero.